You are here: Industry Insights > Amgen

News List

Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries prnewswire
June 23, 2020
Amgen announced it is supporting the further study of AMG 634, a phosphodiesterase type 4 (PDE4) inhibitor, for the treatment of tuberculosis (TB) and erythema nodosum leprosum (ENL), an inflammatory cutaneous and systemic complication of leprosy.
Amgen Announces Positive Top-Line Results from Otezla Plaque Psoriasis Study americanpharmaceuticalreview
May 08, 2020
Amgen announced positive top-line results from the ADVANCE trial, a Phase 3, multicenter, randomized, placebo-controlled, double-blind study to assess the efficacy of Otezla® (apremilast) in adults with mild-to-moderate plaque psoriasis.
Financial Report - Amgen contractpharma
May 04, 2020
Newer products, including Otezla, Repatha, MVASI, KANJINTI and Evenity, partially offset declines due to biosimilar competition.
Amgen and Adaptive Biotechnologies to develop Covid-19 drug pharmaceutical-technology
April 06, 2020
Amgen has partnered with Adaptive Biotechnologies to develop a drug candidate that could prevent and treat Covid-19 coronavirus infection.
Amgen, Adaptive Biotech Enter COVID-19 Antibody Alliance contractpharma
April 03, 2020
Aims to accelerate the development of a potential antibody against COVID-19 as fast as possible.
Amgen and the Amgen Foundation commit up to $12.5 million to support COVID-19 relief efforts worldpharmanews
March 27, 2020
Amgen and the Amgen Foundation announced an initial commitment of up to $12.5 million to support U.S. and global relief efforts to address critical needs in communities impacted by the COVID-19 pandemic.
Ten drugs in pre-registration phase have potential to reach blockbuster status by 2025: GlobalData expresspharma
March 13, 2020
Amgen and Allergan’s biosimilar candidate to Roche’s Rituxan (rituximab) shows the greatest potential of these drugs.
Amgen, Cytokinetics, Servier Announce Continuation of GALACTIC-HF americanpharmaceuticalreview
March 05, 2020
Amgen, Cytokinetics, and Servier announced the Data Monitoring Committee (DMC) for GALACTIC-HF recently completed the second and final planned interim analysis ...
Amgen announces global diagnostic collaborations worldpharmanews
January 14, 2020
Amgen announced strategic collaborations with leading diagnostic companies Guardant Health, Inc. and QIAGEN N.V. to develop blood- and tissue-based companion diagnostics (CDx), respectively, for investigational cancer treatment AMG 510.
Amgen commences strategic collaboration with BeiGene to expand oncology presence in China worldpharmanews
January 07, 2020
Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world's second-largest pharmaceutical market.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page